Melmed, Gil Y <br/><br/>
Human Placenta-derived Cells (PDA-001) for the Treatment of Moderate-to-severe Crohn's Disease: A Phase 1b/2a Study.  [electronic resource] 

 -  Inflammatory bowel diseases  Aug 2015 
 - 1809-16 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1536-4844 
<br/><br/><label>Standard No.: </label>10.1097/MIB.0000000000000441  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Cell- and Tissue-Based Therapy<br/>Cells, Cultured<br/>Crohn Disease--pathology<br/>Double-Blind Method<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Maximum Tolerated Dose<br/>Middle Aged<br/>Placenta--cytology<br/>Pregnancy<br/>Prognosis<br/>Quality of Life<br/>Remission Induction<br/>Safety<br/>Young Adult